100 related articles for article (PubMed ID: 16932341)
1. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
[TBL] [Abstract][Full Text] [Related]
2. CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia.
Sivina M; Hartmann E; Kipps TJ; Rassenti L; Krupnik D; Lerner S; LaPushin R; Xiao L; Huang X; Werner L; Neuberg D; Kantarjian H; O'Brien S; Wierda WG; Keating MJ; Rosenwald A; Burger JA
Blood; 2011 Feb; 117(5):1662-9. PubMed ID: 21115978
[TBL] [Abstract][Full Text] [Related]
3. CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.
Damle RN; Temburni S; Calissano C; Yancopoulos S; Banapour T; Sison C; Allen SL; Rai KR; Chiorazzi N
Blood; 2007 Nov; 110(9):3352-9. PubMed ID: 17684154
[TBL] [Abstract][Full Text] [Related]
4. Improved ZAP-70 assay using two clones, multiple methods of analysis and clinical correlation.
Degheidy HA; Venzon DJ; Farooqui MZ; Abbasi F; Arthur DC; Wilson WH; Wiestner A; Stetler-Stevenson MA; Marti GE
Cytometry B Clin Cytom; 2011 Sep; 80(5):309-17. PubMed ID: 21472850
[TBL] [Abstract][Full Text] [Related]
5. Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia.
Kujawski L; Ouillette P; Erba H; Saddler C; Jakubowiak A; Kaminski M; Shedden K; Malek SN
Blood; 2008 Sep; 112(5):1993-2003. PubMed ID: 18436738
[TBL] [Abstract][Full Text] [Related]
6. Prognostic information and biological insights in chronic lymphocytic leukemia by high-resolution immunophenotypic analysis of ZAP70.
Kaplan D; Sun Z; Tallman MS; Flinn IW; Xiao W; Caimi PF; Kaye NM; Lazarus HM
Cytometry A; 2014 Sep; 85(9):798-808. PubMed ID: 24845539
[TBL] [Abstract][Full Text] [Related]
7. Methodological comparison of two anti-ZAP-70 antibodies.
Degheidy HA; Venzon DJ; Farooqui MZ; Abbasi F; Arthur DC; Wilson WH; Wiestner A; Stetler-Stevenson MA; Marti GE
Cytometry B Clin Cytom; 2011 Sep; 80(5):300-8. PubMed ID: 21472849
[TBL] [Abstract][Full Text] [Related]
8. Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia.
Ronchetti D; Mosca L; Cutrona G; Tuana G; Gentile M; Fabris S; Agnelli L; Ciceri G; Matis S; Massucco C; Colombo M; Reverberi D; Recchia AG; Bossio S; Negrini M; Tassone P; Morabito F; Ferrarini M; Neri A
BMC Med Genomics; 2013 Sep; 6():27. PubMed ID: 24004562
[TBL] [Abstract][Full Text] [Related]
9. Smudge cell percentage as a surrogate marker for ZAP-70 expression in patients with chronic lymphocytic leukemia.
Al-Kahiry W; Tawfik HS; Sharshira H; Ghanem A; El-Gammal M; Mikhael IL
Blood Res; 2018 Sep; 53(3):218-222. PubMed ID: 30310788
[TBL] [Abstract][Full Text] [Related]
10. Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances.
Huang G; Jian J; Liu CJ
Cytokine Growth Factor Rev; 2024 Apr; 76():142-159. PubMed ID: 37981505
[TBL] [Abstract][Full Text] [Related]
11. Targeting Pim kinases in hematological cancers: molecular and clinical review.
Bellon M; Nicot C
Mol Cancer; 2023 Jan; 22(1):18. PubMed ID: 36694243
[TBL] [Abstract][Full Text] [Related]
12. Targeting PIM Kinases to Improve the Efficacy of Immunotherapy.
Clements AN; Warfel NA
Cells; 2022 Nov; 11(22):. PubMed ID: 36429128
[TBL] [Abstract][Full Text] [Related]
13. Proteogenomics refines the molecular classification of chronic lymphocytic leukemia.
Herbst SA; Vesterlund M; Helmboldt AJ; Jafari R; Siavelis I; Stahl M; Schitter EC; Liebers N; Brinkmann BJ; Czernilofsky F; Roider T; Bruch PM; Iskar M; Kittai A; Huang Y; Lu J; Richter S; Mermelekas G; Umer HM; Knoll M; Kolb C; Lenze A; Cao X; Österholm C; Wahnschaffe L; Herling C; Scheinost S; Ganzinger M; Mansouri L; Kriegsmann K; Kriegsmann M; Anders S; Zapatka M; Del Poeta G; Zucchetto A; Bomben R; Gattei V; Dreger P; Woyach J; Herling M; Müller-Tidow C; Rosenquist R; Stilgenbauer S; Zenz T; Huber W; Tausch E; Lehtiö J; Dietrich S
Nat Commun; 2022 Oct; 13(1):6226. PubMed ID: 36266272
[TBL] [Abstract][Full Text] [Related]
14. Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertension.
Sanges S; Guerrier T; Duhamel A; Guilbert L; Hauspie C; Largy A; Balden M; Podevin C; Lefèvre G; Jendoubi M; Speca S; Hachulla É; Sobanski V; Dubucquoi S; Launay D
Front Immunol; 2022; 13():954007. PubMed ID: 35967377
[TBL] [Abstract][Full Text] [Related]
15. A Ferroptosis Molecular Subtype-Related Signature for Predicting Prognosis and Response to Chemotherapy in Patients with Chronic Lymphocytic Leukemia.
Gong H; Li H; Yang Q; Zhang G; Liu H; Ma Z; Peng H; Nie L; Xiao X; Liu J
Biomed Res Int; 2022; 2022():5646275. PubMed ID: 35845961
[TBL] [Abstract][Full Text] [Related]
16. Proviral Integration of Moloney Virus-2 (PIM-2) Expression Level as a Prognostic Marker in Patients with Acute Myeloid Leukemia.
Hamed G; Omar HM; Sarhan AM; Salah HE
Int J Gen Med; 2022; 15():4247-4258. PubMed ID: 35480994
[TBL] [Abstract][Full Text] [Related]
17. ENDOG Impacts on Tumor Cell Proliferation and Tumor Prognosis in the Context of PI3K/PTEN Pathway Status.
Barés G; Beà A; Hernández L; Navaridas R; Felip I; Megino C; Blasco N; Nadeu F; Campo E; Llovera M; Dolcet X; Sanchis D
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359707
[TBL] [Abstract][Full Text] [Related]
18. DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity.
Valle-Argos B; Chiodin G; Bryant DJ; Taylor J; Lemm E; Duriez PJ; Rock PJ; Strefford JC; Forconi F; Burack RW; Packham G; Stevenson FK
Sci Rep; 2021 Jun; 11(1):11676. PubMed ID: 34083646
[TBL] [Abstract][Full Text] [Related]
19. IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics.
Nadeu F; Royo R; Clot G; Duran-Ferrer M; Navarro A; Martín S; Lu J; Zenz T; Baumann T; Jares P; Puente XS; Martín-Subero JI; Delgado J; Campo E
Blood; 2021 May; 137(21):2935-2946. PubMed ID: 33211804
[TBL] [Abstract][Full Text] [Related]
20. Dissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic Leukemia.
Schulze-Edinghausen L; Dürr C; Öztürk S; Zucknick M; Benner A; Kalter V; Ohl S; Close V; Wuchter P; Stilgenbauer S; Lichter P; Seiffert M
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31200555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
